Complete Suppression of Tumor Formation by High Levels of Basement Membrane Collagen

Suppression of tumorigenicity was first shown in hybrids produced by the fusion of a range of different highly malignant tumor cells with diploid fibroblasts. Cytogenetic analysis of these hybrids revealed that suppression involved a genetic region located in one specific chromosome donated to the hybrid cell by the fibroblast parent. The identity of the gene responsible for this dramatic effect has remained obscure. We now present strong evidence that the primary determinant is the gene specifying collagen XV, a proteoglycan closely associated with the basement membrane. We transfected a line of highly tumorigenic human cervical carcinoma cells with an expression vector carrying the full-length cDNA of the human collagen XV gene. We selected clones making various amounts of collagen XV, examined their growth in vitro, and tested their tumorigenicity in nude mice. High levels of collagen XV altered the growth properties of the cells in three-dimensional cultures. Moreover, we found that, in a dose-dependent manner, the production of collagen XV completely suppressed tumorigenicity in clones that synthesized this molecule at high levels. Immunohistologic studies suggest that suppression is associated with extracellular deposition of the proteoglycan at the cell periphery. (Mol Cancer Res 2007;5(12):1241–5)

[1]  R. Poulsom,et al.  Collagen XXVII Is Developmentally Regulated and Forms Thin Fibrillar Structures Distinct from Those of Classical Vertebrate Fibrillar Collagens* , 2007, Journal of Biological Chemistry.

[2]  Kerstin Radtke,et al.  Identification and characterization of novel endogenous proteolytic forms of the human angiogenesis inhibitors restin and endostatin. , 2005, Biochimica et biophysica acta.

[3]  T. Kanekura,et al.  Immunohistochemical studies comparing the localization of type XV collagen in normal human skin and skin tumors with that of type IV collagen. , 2005, Journal of dermatology (Print).

[4]  J. Myers,et al.  Proteoglycan-Collagen XV in Human Tissues Is Seen Linking Banded Collagen Fibers Subjacent to the Basement Membrane , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[5]  H. Harris Is collagen XV a tumor suppressor? , 2003, DNA and cell biology.

[6]  N. Barnard,et al.  Loss of types XV and XIX collagen precedes basement membrane invasion in ductal carcinoma of the female breast , 2003, The Journal of pathology.

[7]  Parvaneh Saeedi,et al.  A physical map of the mouse genome , 2002, Nature.

[8]  P. Söderkvist,et al.  Regional mapping of suppressor loci for anchorage independence and tumorigenicity on human chromosome 9. , 2001, Cancer genetics and cytogenetics.

[9]  L Eklund,et al.  Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Myers,et al.  Basement Membrane Zone Type XV Collagen Is a Disulfide-bonded Chondroitin Sulfate Proteoglycan in Human Tissues and Cultured Cells* , 2000, The Journal of Biological Chemistry.

[11]  V. Sukhatme,et al.  Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. , 1999, Biochemical and biophysical research communications.

[12]  S. Peltonen,et al.  Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. , 1997, The American journal of pathology.

[13]  J. Myers,et al.  Type XV collagen exhibits a widespread distribution in human tissues but a distinct localization in basement membrane zones , 1996, Cell and Tissue Research.

[14]  H. Harris,et al.  The suppression of malignancy by terminal differentiation: evidence from hybrids between tumour cells and keratinocytes. , 1987, Journal of cell science.

[15]  H. Harris Suppression of malignancy in hybrid cells: the mechanism. , 1985, Journal of cell science.

[16]  H. Harris,et al.  The analysis of malignancy by cell fusion. IX. Re-examination and clarification of the cytogenetic problem. , 1982, Journal of cell science.

[17]  E. Stanbridge,et al.  Characterization of human keratinocyte , 1981 .

[18]  E. Stanbridge,et al.  Characterization of human keratinocyte X HeLa somatic cell hybrids. , 1981, International journal of cancer.

[19]  S. Povey,et al.  The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. , 1977, Journal of cell science.

[20]  H Harris,et al.  The analysis of malignancy by cell fusion. I. Hybrids between tumour cells and L cell derivatives. , 1971, Journal of cell science.